Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2005
08/18/2005WO2005075655A2 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
08/18/2005WO2005075652A1 Process for producing modified ϝ-glutamyltranspeptidase (modified ggt) having enhanced glutaryl-7-aminosephalosporanic acid (gl-7-aca) acylase activity
08/18/2005WO2005075650A1 Polypeptide having amidase activity and gene thereof
08/18/2005WO2005075649A1 Method of producing recombinant sucrose synthase, use thereof in the production of sucrose-determination kits, method of producing adpglucose and method of obtaining transgenic plants having leaves and reserve organs which accumulate a high concentration of adpglucose and starch
08/18/2005WO2005075635A2 Coagulation factor vii/viia variants lacking a functional lipid membrane binding domain
08/18/2005WO2005075634A1 Diagnostics and therapeutics for diseases associated with kallikrein 12 (klk12)
08/18/2005WO2005075633A1 Removal of print paste thickener from textile
08/18/2005WO2005075632A2 Treatment of neurodegenerative diseases by the use of atp7a-modulators
08/18/2005WO2005075631A1 Process for the preparation of l-amino acids with amplification of the zwf gene
08/18/2005WO2005075630A2 New acylglycerol acyltransferase-like proteins dc4 and uses thereof
08/18/2005WO2005075627A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
08/18/2005WO2005074941A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
08/18/2005WO2005074906A1 Remedy
08/18/2005WO2005074707A1 Stabilized phosphatase formulations
08/18/2005WO2005074705A1 Stabilized enzyme formulations
08/18/2005WO2005074677A1 Transgenic animals for assessing drug metabolism and toxicity in man
08/18/2005WO2005074656A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/18/2005WO2005074647A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/18/2005WO2005074605A2 Recombinant molecular products for expression of heme oxygenase-1, heme oxygenase-2, and/or biliverdin reductase for treatment of neurodegenerative diseases or disorders
08/18/2005WO2005074350A2 Mutated dna polymerases with increased mispairing discrimination
08/18/2005WO2005060996A3 Method of altering the pka type i signalling pathway
08/18/2005WO2005029067A3 Method of diagnosing breast cancer
08/18/2005WO2004100873A3 Compounds, compositions, and methods
08/18/2005WO2004084821A3 Hemipteran glutamate decarboxylase
08/18/2005WO2004035729A3 Esterases, nucleic acids encoding them and methods of making and using them
08/18/2005WO2004018645A3 Utilization of starch products for biological production by fermentation
08/18/2005WO2003089610A3 Fatty alcohol oxidase genes and proteins from candida troplicalis and methods relating thereto
08/18/2005WO2003004608A3 Drug metabolizing enzymes
08/18/2005US20050183168 Plants having decreased dormancy period and methods producing the plants
08/18/2005US20050183164 Isolated polynucleotide of a nucleotide sequence encoding a polypeptide having hydroxylmethylglutaryl-CoA synthase activity
08/18/2005US20050183163 Mevalonate synthesis enzymes
08/18/2005US20050183159 Floral organ tissue-specific expression of isopentenyl transferase
08/18/2005US20050183149 Mouse exhibiting characteristics of Rothmund-Thomson syndrome and preparation method thereof
08/18/2005US20050183146 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
08/18/2005US20050183145 Production of ungulates, preferably bovines that produce human immunoglobulins
08/18/2005US20050182248 Adensosine triphosphatase for use as tool to identify modulators for prevention and treatment of obesity, high blood pressure and connective tissue disorders
08/18/2005US20050181996 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
08/18/2005US20050181985 Coupling proteins to a modified polysaccharide
08/18/2005US20050181976 coupled to therapeutic proteins or peptides; biochemical conjugation
08/18/2005US20050181975 Crystal structure of FMS-like tyrosine kinase
08/18/2005US20050181506 Chromosome-based platforms
08/18/2005US20050181493 Mutant alpha-amylases
08/18/2005US20050181492 Ethanol production
08/18/2005US20050181490 Fermentation process for preparing coenzyme Q10 by the recombinant Agrobacterium tumefaciens
08/18/2005US20050181489 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity
08/18/2005US20050181485 Cellulose digesting enzyme gene and utilization of the gene
08/18/2005US20050181484 Culturing porcine bone marrow stem cells in nutrient broth comprising interleukins and colony stimulating factor; propagating mast cell
08/18/2005US20050181480 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells
08/18/2005US20050181478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/18/2005US20050181473 Bacterial adpglucose pyrophospatase method for obtaining the latter and its use in the production of assay devices and in the obtention of transgenic plants and bacteria
08/18/2005US20050181472 proteins from Pseudomonas, having butynol I esterase activity; nucleotides sequences codes; expression cassettes, vectors and genetic engineered microorganisms; used for stereospecific hydrolysis or transesterification of organic esters
08/18/2005US20050181471 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits
08/18/2005US20050181464 Recombinant enoyl-(acyl-carrier-protein) reductase (NADH) for use as tool in identifying modulators which prevent microbial infection; bactericides
08/18/2005US20050181446 Protein variants having modified immunogenicity
08/18/2005US20050181444 related to the Pftaire kinase subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; models for human therapeutic targets; expression in humans in uterus endometrium adenocarcinoma, testis, lung fibroblasts, kidney renal cell adenocarcinoma, and the brain
08/18/2005US20050181437 UDP-galactose: beta-N acetyl-glucosamine beta-1, 4-galactosyltransferase, beta4 Gal-T2
08/18/2005US20050181435 Mixture comprising thermostable structure-specific flap structure-specific endonuclease-1 (FEN-1) for use in cancer diagnosis and microorganismal detection
08/18/2005US20050181434 Glucuronyl C5-epimerase, DNA encoding the same and uses thereof
08/18/2005US20050181415 Drug metabolizing enzymes
08/18/2005US20050181414 Peptides associated with serine protease active site for use in identification of modulators for treatment of cell proliferative disorders
08/18/2005US20050181404 Proteolytic enzyme for use as tool in identifying modulators for prevention and treatment of cell proliferative and immune disorders
08/18/2005US20050181402 Immunoglobulin which specifically binds serum and glucocorticoid dependent kinase for diagnosing infection, inflammatory, kidney and liver disorders
08/18/2005US20050181388 Novel purified polypeptides from bacteria
08/18/2005US20050181375 Using presence of metastatic lung cancer-associated transcripts as diagnostic tool in diagnosis, prognosis and characterization of cell proliferative disorders
08/18/2005US20050181362 Aligning the test nuclear receptor (NR) polypeptide, with at least one reference NR polypeptide sequence for which an X-ray structure is available; building a three-dimensional model for the test NR polypeptide, examining the three-dimensional model of the test NR polypeptide sequence for difference
08/18/2005US20050181358 Soluble complex comprising a retroviral surface glycoprotein
08/18/2005US20050181355 Compositions and methods for the modulation of viral maturation
08/18/2005US20050180996 Vaccine composition specific to glyceroaldehyde-3-phosphate dehydrogenase for use as tool in prevention and treatment of coccidiosis; veterinary medicine
08/18/2005US20050180981 Human checkpoint kinase, hCDS1, compositions and methods
08/18/2005US20050180959 Kinases involved in the regulation of energy homeostasis
08/18/2005DE102004004924A1 A141S-und G399S-Mutation im Omi/HtrA2-Protein bei Morbus Parkinson A141S and G399S mutation in the Omi / HtrA2 protein in Parkinson's disease
08/18/2005CA2556161A1 Heparan-sulfate proteoglycan degrading enzymes for promotion of nerve regeneration
08/18/2005CA2555632A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
08/18/2005CA2554784A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/18/2005CA2554780A1 Method of producing recombinant sucrose synthase, use thereof in the production of sucrose-determination kits, method of producing adpglucose and method of obtaining transgenic plants having leaves and reserve organs which accumulate a high concentration of adpglucose and starch
08/18/2005CA2554644A1 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
08/18/2005CA2554431A1 Genetic markers for skatole metabolism
08/18/2005CA2554362A1 Treatment of neurodegenerative diseases by the use of atp7a inhibitors
08/17/2005EP1564557A1 Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
08/17/2005EP1564298A1 Enzymatic asymmetric decarboxylation of disubstituted malonic acids
08/17/2005EP1564297A1 Control of programmed cell death (PCD) in plants
08/17/2005EP1564296A1 Stress tolerance and delayed senescence in plants
08/17/2005EP1564289A1 Stabilization of linear double-stranded DNA in the presence of exonucleases
08/17/2005EP1564288A1 Function-modified thermophilic DNA polymerase
08/17/2005EP1564286A1 Hybrid proteins of beta-lactamase class A
08/17/2005EP1563094A2 Modulators of angiogenesis and tumorigenesis
08/17/2005EP1563065A2 Method of preparing cross-linked enzyme particles
08/17/2005EP1563064A2 Subtilase variants
08/17/2005EP1563063A2 Calmodulin independent activation of nitric oxide synthase by nadph analogs
08/17/2005EP1563060A2 Tps plant gene constructs and transformants
08/17/2005EP1562630A2 Injectible bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
08/17/2005EP1512007A4 32235, a human aminotransferase family member and uses therefor
08/17/2005EP1466174A4 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
08/17/2005EP1463809B1 Mutation of dna polymerases from archaeobacteria
08/17/2005EP1419392A4 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs
08/17/2005EP1287146B1 Cold sensitive mutant dna polymerases
08/17/2005EP1254141B1 Camptothecin -beta-alanine esters with topoisomerase i inibhition
08/17/2005EP1109908B1 Methods for determining compounds for modulating the body weight
08/17/2005EP1088082B1 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
08/17/2005EP1073723B1 Ste20-related protein kinases
1 ... 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 ... 1416